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Abstract:  Acetylcholinesterase-inhibiting activity of marinoquinoline A (1), a new 
pyrroloquinoline from a novel species of a marine gliding bacterium Rapidithrix 
thailandica, was assessed (IC50 4.9 μM).  Two related pyrrole derivatives, 3-(2'-
aminophenyl)-pyrrole  (3)  and 2,2-dimethyl-pyrrolo-1,2-dihydroquinoline (4), were also 
isolated from two other strains of R. thailandica.  The isolation of 3 from a natural source 
is reported here for the first time.  Compound 4 was proposed to be an isolation artifact 
derived from 3.  The two isolated compounds were virtually inactive in the 
acetylcholinesterase-inhibitory assay (enzyme inhibition < 30% at 0.1 g L
-1).   
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1.  Introduction  
One of the most important roles of acetylcholine in the brain is to govern the connectivity among 
neurons, thereby regulating the brain’s cognitive functions.  A deficit in acetylcholine, especially in 
the basal forebrains, is a neurochemical characteristic of patients clinically diagnosed with 
Alzheimer’s disease (AD).  Using acetylcholinesterase (AChE) inhibitors to retard the catabolic 
hydrolysis of acetylcholine, therefore compensating such deficiency particularly at the synaptic 
terminals, has been suggested as one of the most direct remedies for AD treatment.  To date, only three 
AChE inhibitors; donepezil, rivastigmine, and galantamine, have been approved by US FDA for the 
treatment of AD.  Whereas it is arguable whether such drugs provide a long-term treatment or are 
merely a symptom intervention, they are one of only a few effective approaches available for the 
treatment of AD [1,2].   
Recently, we reported the isolation and structure elucidation of marinoquinoline A (1), a new 
alkaloid possessing an unprecedented pyrrolo[2,3-c]quinoline skeleton from a novel marine gliding 
bacterium Rapidithrix thailandica [3,4].  The structural similarity between 1 and tacrine (2), a potent 
AChE inhibitor, prompted us to subject the compound to the AChE inhibiting assay, as well as to 
search for additional pyrrole/pyrroloquinoline derivatives from the bacterium.  Here, the isolation and 
structure determination of the phenylpyrrole analogs of 1 will be reported, along with the AChE-
inhibiting activity of 1 and related compounds.   
2. Results and Discussion   
Marinoquinoline A (1) was obtained from the gliding bacterium R. thailandica TISTR 1742 as 
reported earlier [3].  Given the close resemblance between 1 and 2, we speculated that 1 might bind to 
the enzyme AChE in a manner similar to that of 2.  Consequently, 1 was assayed against AChE using 
Torpedo californica AChE.  As expected, the compound exhibited a strong inhibition with an IC50 of 
4.9±0.9  μM (referred to standard galantamine, IC50 0.6±0.1  μM) with no appreciable cytotoxicity 
against the panel of cancer cell lines (> 80% cell viability at 20 μM).   
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Based on the promising results, two other strains of R. thailandica were selected for the chemical 
investigation in an effort to discover related pyrrole/pyrroloquinoline derivatives.  The gliding 
bacterial strains TISTR 1749 and SH5.13.2 were separately isolated from a submerged sea grass blade 
collected from Fossil Shell Beach Park, Krabi Province, and from debris collected from Koh-Kham, 
Chonburi Province, respectively.  The 16S rDNA analysis of the bacterial isolates suggested that they 
were identical to each other.  The BLAST search with the 16S rDNA gene sequences in GenBank 
database indicated that both strains belonged to the gliding bacterium R. thailandica, gen. nov., sp. 
nov. (family Flammeovirgaceae), with 99% similarity in gene sequences to the type strain TISTR 
1750
T [4].   
The large scale fermentations of strains TISTR 1749 and SH5.13.2 were carried out in skim milk 
and CY media, respectively.  Amberlite XAD-16, added to the fermentation broths of each strain, was 
harvested and eluted with MeOH, and each extract was subjected to the further chromatographic 
separation.  Extract from the strain TISTR 1749 yielded 3 and 4, whereas that of SH5.13.2 yielded 3 as 
the main product.   
Compound 3 possesses a molecular formula of C10H10N2 according to the molecular ion signal at 
m/z 158 observable in the EI mass spectrum.  This was confirmed by the high resolution mass of 
158.0852 (EI; calc for C10H10N2 158.0842).  The 
1H NMR spectrum (500 MHz, DMSO-d6, Table 1) 
showed nine resonances, seven of which belonged to two aromatic spin systems, while the other two 
were exchangeable proton signals.  The first aromatic spin system, resonating at δ 6.55 (ddd, J = 7.5, 
7.3, 1.3 Hz; H-5'), 6.69 (dd, J = 7.9, 1.3 Hz; H-3'), 6.88 (ddd, J = 7.9, 7.3, 1.3 Hz; H-4'), and 7.10 (dd, 
J = 7.5, 1.5 Hz; H-6'), was characteristic to a 1,2-disubstituted benzene ring.  Another spin system was 
elucidated as 3-substituted pyrrole moiety according to the characteristic proton signals at δ 6.25 (ddd, 
J = 2.5, 2.3, < 1 Hz; H-4), 6.83 (ddd, J = 2.5, 2.3, 2.3 Hz; H-5), and 6.96 (ddd, J = 2.3, 2.3, < 1Hz; H-
2).  This agreed well with the observation of the low-fielded exchangeable proton at δ 10.90 (br s), 
typically assigned to H-1 of pyrrole.  The connection of the two aromatic rings was achieved via the 
HMBC long-range correlation from C-3 to H-6'.  The presence of a primary amino group was deduced 
from the characteristic IR absorption band at νmax 3400 cm
-1, and from the exchangeable proton 
resonance at δ 4.70 (br s, 2H; 2'-NH2).  Attachment of the amino group onto C-2' (δ 144.8) of the 
phenyl ring furnished the structure of 3 as 3-(2'-aminophenyl)-pyrrole.  The nOe between each pair of 
protons along the circumference of the structure, i.e., H-1 ↔ H-2 ↔ 2'-NH2 ↔ H-3' ↔ H-4' ↔ H-5' ↔ 
H-6' ↔ H-4 ↔ H-5 ↔ H-1, strongly supported the proposed structure.  The structure of 3 has been 
proposed as one of theoretical biosynthetic intermediates of the antibiotic pyrronitrin (5) [5-7], 
previously reported from several pseudomonads and related bacteria [5,8-10].  This hypothesis was 
challenged in a recent report by Kirner et al [11], who suggested that 3 was in fact either a side product 
or biosynthetic dead-end of 5.  In either case, however, 3 has never been actually isolated from any 
natural sources. 
The molecular formula of 4 was proposed to be C13H14N2 as deduced from the high resolution mass 
at  m/z 198.1122 in the HR-EI mass spectrum (calc for C13H14N2 198.1154).  From the 
1H NMR 
spectrum (500 MHz, DMSO-d6, Table 2), seven proton resonances characteristic of a 1,2-disubstituted 
benzene (δ 6.45, ddd, J = 7.7, 7.5, 1.0 Hz, H-7; 6.50, dd, J = 7.9, 1.0 Hz, H-9; 6.73, ddd, J = 7.9, 7.7, 
1.3 Hz, H-8; and 7.08, dd, J = 7.5, 1.3 Hz, H-6) and of a 2,3-disubstituted pyrrole (δ 6.20, dd, J = 2.6, 
2.4 Hz, H-5; 6.64, dd, J = 2.8, 2.6 Hz, H-4; and 10.74, br s, H-1) suggested that 3 and 4 were closely Mar. Drugs 2008, 6                                                  
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related.  The 40 mass units higher than that of 3, and the additional NMR signals, which include those 
of a quarternary carbon at δ 52.1 (C-2) and two geminal methyl at δH 1.42 (s, 6H; 2-CH3) and δC 30.6 
(2C), indicated that 4 was a dimethyl dihydroquinoline analog of 3.  The structure of 4 was therefore 
proposed as 2,2-dimethyl-pyrrolo-1,2-dihydroquinoline.  Also, similar to 3, a network of nOes along 
the circumference of the structure was observed, which strongly supported the proposed structure of 4.   
Table 1. NMR spectral data of 3 (DMSO-d6; 500 MHz for 
1H). 
position 
1H
a (mult.; J in Hz) 
13C (mult.) 
1  10.90 (br s)  - 
2  6.96 (ddd; 2.3,2.3,<1)  115.8 (CH) 
3 -  121.1  (C) 
4  6.25 (ddd; 2.5,2.3,<1)  107.3 (CH) 
5  6.83 (ddd; 2.5,2.3,2.3)  118.3 (CH) 
1' -  121.6  (C) 
2' -  144.8  (C) 
3'  6.69 (dd; 7.9,1.3)  115.2 (CH) 
4'  6.88 (ddd; 7.9,7.3,1.5)  126.2 (CH) 
5'  6.55 (ddd; 7.5,7.3,1.3)  116.9 (CH) 
6'  7.10 (dd; 7.5,1.5)  128.9 (CH) 
2'-NH2  4.20 (br s; 2H)  - 
Note:
 aUnless stated otherwise, each proton signal integrated as 1 H. 
 
Table 2. NMR spectral data of 4 (DMSO-d6; 500 MHz for 
1H). 
position 
1H
a (mult.; J in Hz) 
13C
b (mult.) 
1  5.70 (br s)  - 
2 - 52.1  (C) 
2a - 132.2  (C) 
3  10.74 (br s)  - 
4  6.64 (dd; 2.8,2.6)  117.8 (CH) 
5  6.20 (dd; 2.6,2.4)  101.5 (CH) 
5a - 113.5  (C) 
5b -  119.1  (C) 
6  7.08 (dd; 7.5,1.3)  121.0 (CH) 
7  6.45 (ddd; 7.7,7.5,1.0)  116.2 (CH) 
8  6.73 (ddd; 7.9,7.7,1.3)  125.0 (CH) 
9  6.50 (dd; 7.9,1.0)  112.7 (CH) 
9a - 141.7  (C) 
2-CH3  1.42 (s; 6H)  30.6 (CH3, 2C) 
Note:
  a Unless stated otherwise, each proton signal integrated as 1 H. 
b Unless stated otherwise, each carbon signal is equivalent to 1 C. 
 
Whereas the fermentation broth of strain TIRTR 1749 led to the isolation of two major components, 
that of SH5.13.2 primarily yielded only 3. The difference in the chemical compositions between the 
two strains raised the questions whether 4 was genuinely produced by R. thailandica TISTR 1749 or 
whether the compound was in fact an isolation artifact.  Careful examination of the 
1H NMR spectra of Mar. Drugs 2008, 6                                                  
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the MeOH extract and subsequent fractions showed that only after the first chromatographic step, in 
which acetone was extensively used, were all the resonances related to 4, especially the prominent 
methyl signal, observable.  This suggested that 4 was potentially an artifact, presumably generated 
from SiO2-catalyzed Pictet-Spengler reaction between 3 and acetone.  This was also supported by the 
absence of 4 in the extract from strain SH5.13.2, where acetone was avoided.  
The AChE inhibitory activity and cytotoxicity of 3 and 4 were assessed.  Surprisingly, both were 
inactive in the AChE inhibition and in the cytotoxicity bioassays (enzyme inhibition < 30% at 0.1 g L
-
1; > 80% cell viability at 20 g L
-1, respectively).  Despite sharing a related skeleton, the three 
compounds exhibited different activities.  It is proposed here that the binding behavior to AChE of the 
pyrroloquinolines may relate to the extended aromaticity of the quinoline moiety of 2, which may have 
π,π-interaction in the gorge of AChE [12,13].   
In summary, we have demonstrated the potential of 1 as a new and potent AChE inhibitor.  The 
investigation of two other strains of the novel marine gliding bacterium R. thailandica also led to the 
isolation of pyrrole derivatives, 3 and 4.  Although 4 was suggested here as a possible isolation artifact 
generated from the condensation between 3 and acetone, the structures of the two isolated compounds 
have nonetheless never been reported from any natural and wild-type bioresources.  In addition, 
without any intermediates related to 5 observable in the extract, the isolation of 3 as a major 
component from the marine gliding bacterium confirms the previous conclusion contributed in [11] 
that, unless produced from otherwise entirely different biosynthetic pathway, 3 (and presumably 1) can 
be presumed as a biosynthetic dead-end branched from that of 5, which are commonly found in several 
terrestrial bacteria.   
3. Experimental  
3.1. General 
Unless stated otherwise, all chemicals, chromatographic solvents, and media were used as 
purchased.  Sea water for all media preparation was filtered through cotton plug before used.  The 
classical chromatographic separations were all performed using SiO2 (Scharlau
®, 230-400 mesh), 
whereas the size-exclusion one was operated on a Sephadex LH20 (GE Helathcare
®) column.   
Preparative HPLC was performed on a Water
® 600E multisolvent delivery system, which was 
connected to a Water
® 484 UV detector, and a Rheodyne
® 7125 injector port.  IR spectra were 
obtained from a Jasco IR-810 infrared spectrometer.  UV spectra were measured on a Spectronic 
Genesys 5 spectrometer.  Mass spectra were operated on a Micromass LCT mass spectrometer.  The 
NMR experiments were performed on a 500-MHz FT-NMR Varian Unity Inova 500 spectrometer, and 
were all referenced to the solvent signals (DMSO-d6; δ 2.49 of trace C2D5HSO for 
1H; δ 39.7 for 
13C) 
as the internal standard.   
3.2. Bacterial isolation and purification 
The gliding bacteria TISTR 1749 and SH5.13.2 were isolated from a submerged sea grass blade 
collected from Fossil Shell Beach Park, Krabi Province, and from debris collected from Koh-Kham, Mar. Drugs 2008, 6                                                  
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Chonburi Province, respectively.  For each isolate, a small piece of the collected specimen was cut and 
allowed to stand at an ambient temperature on a Petri dish of either SWG medium (for TISTR 1749) 
containing (g L
-1 of sea water) monosodium L-glutamate (1), NH4NO3 (0.01), K2HPO4 (0.01), agar 
(15) [14]; or a crystal violet-supplemented (1 g L
-1) SWG medium (for SH5.13.2) [modified from 15].  
Once swarm colonies were observed, a cut piece of agar medium bearing one clean edge of each 
colony was transferred to a new subculture plate of SAP2 solid medium, containing (g L
-1 of sea water) 
tryptone (1) and agar (15) [14, modified from 16].  The pure culture of the strain TISTR 1749 was 
obtained by means of micromanipulation technique [3,14], whereas that of SH5.13.2 was via repeated 
subculturing on SAP2 medium at ambient temperature.  The reference culture of the strain TISTR 1749 
was lodged at the culture collection of Thailand Institute of Scientific and Technological Research, 
Pathum-Thani, Thailand, and that of SH5.13.2 was at the Marine Biotechnology Laboratory, 
Department of Industrial Biotechnology, Faculty of Agro-Industry, Prince of Songkla University, 
Songkhla, Thailand.   
3.3. Taxonomic identification 
The taxonomic identification of both strains was based on the 16S rDNA analysis, performed as 
described in [3,14].  In brief, the 16S rDNA was amplified by PCR technique using the 16S rDNA 
universal primers BF1 and BR1.  The purification of the PCR products was carried out using GFX 
PCR DNA and gel band purification kit (Amersham
®).  Sequencing reaction was performed using the 
ABI PRISM BigDye Terminator cycle sequencing kit (Applied Biosystem
®).  Sequencing was edited 
and assembled using the BioEdit program [17] and partial 16S rDNA sequences were compared with 
those available in the DNA databases using the BLASTN algorithm for close evolutionary relatives.  
The complete 16S rDNA sequences determined for representative strains of each group were aligned 
with the sequences of reference organisms derived from the database using the ClustalX 1.8.   
3.4. Large scale fermentation 
The medium for pre-culture and large-scale production of each strain of the gliding bacteria was as 
followed; SAP2 liquid medium (g L
-1 of sea water) containing tryptone (1), yeast extract (1) [14, 
modified from 16]; CY medium (g L
-1 of sea water) containing casitone (10), malt extract (2), yeast 
extract (1) [modified from 18]; skim milk medium (g L
-1 of sea water) containing skim milk powder 
(5), yeast extract (3) [modified from 19].  
The pre-culture of each bacterial strain was performed separately in 250-mL flasks each containing 
30 mL of SAP2 liquid medium (72 h, 25°C, 200 rev min
-1).  A 5-mL portion of the pre-culture broth 
from each strain was then separately transferred into a 250-mL flask (×80) of 100-mL production 
medium as stated accordingly.  An in promptu extraction was carried out using amberlite XAD-16 
resins (2 g per 100 mL medium), added prior to sterilizing of each aforementioned production medium.  
After a 7-day incubation (25°C, 200 rev min
-1), the resin beads from each strain were separately 
harvested via nylon mesh, rinsed with water, and extracted with MeOH (2×100 mL).   Mar. Drugs 2008, 6                                                  
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3.5. Extraction and compound isolation  
The isolation of 1 was as per our previous report.  The identification was performed on the basis of 
spectral analysis, from which all impurities were undetectable.    
The MeOH extract from the fermentation broth of the strain TISTR 1749 was subjected to a solvent 
partitioning protocol to yield hexane-, CH2Cl2-, and n-BuOH-extracts.  The CH2Cl2-extract, which 
showed prominent 
1H NMR signals for phenylpyrroles, was selected for the further isolation.   The 
chromatography of the extract on a SiO2 column (step gradient solvents, ramping from 20 to 30% 
acetone in hexane, then 5 to 50% MeOH in CH2Cl2), then on a SiO2 HPLC column (250 ×7 mm 
Econosil
®, 10 μm; continuous gradient 5 to 35% i-PrOH in hexane in 15 min, 2 mL min
-1; 254 nm) 
yielded 3 (12 mg; tR 19 min) and 4 (27 mg; tR 13 min).   
The MeOH extract from the broth of SH5.13.2 was directly chromatographed over Sephadex LH20 
(MeOH), followed by RP-C18 HPLC (250×10 mm Phenomenax
®, 10 μm; 70% aq MeOH, 5 mL min
-1; 
210 nm), and 3 (35 mg; tR 31 min) was obtained.   
 
3-(2'-Aminophenyl)-pyrrole (3). Brownish orange glass; UV (MeOH) λmax (log ε) 212 (4.07), 302 
(3.34) nm; IR (thin film) νmax 3400, 2910, 1610 cm
-1; EIMS m/z (% relative intensity) 158 [M
+] (100), 
130 (85), 84 (52), 66 (65); HR-EIMS m/z 158.0853 (calc for C10H10N2 158.0842); 
1H and 
13C NMR 
(DMSO-d6; 500 MHz for 
1H) see Table 1.   
 
2,2-Dimethyl-pyrrolo-1,2-dihydroquinoline (4). Purplish blue glass; UV (MeOH) λmax (log ε) 230 
(4.41), 322 (3.67) nm; IR (thin film) νmax 3400, 2905, 1520, 1450, 1400 cm
-1; EIMS m/z (% relative 
intensity) 198 [M
+] (15), 183 (100); HR-EIMS m/z 198.1122 (calc for C13H14N2 198.1154); 
1H and 
13C 
NMR (DMSO-d6; 500 MHz for 
1H) see Table 2.   
3.6. Bioactivity determination  
The AChE inhibitory assay was conducted (in triplicate) according to the protocol described by 
Ingkaninan et al [20, modified from 21].  To a solution of 125 μL 5,5'-dithiobis[2-nitrobenzoic acid] (3 
mM), 25 μL acetylthiocholine iodide (1.5 mM), 50 μL Tris-HCl buffer (pH 8.0; 5.0 mM), and 25 μL of 
each tested compound in Tris-HCl buffer was added 25 μL Torpedo californica AChE (type VI-S, EC 
3.1.1.7; 0.28 U mL
-1; Sigma
®).  The developing yellow color was measured at 405 nm over 2 min with 
a 5-s interval using a CERES UV900C microplate reader (Bio-Tek Instrument).  The resulting velocity 
was calculated and used for the determination of the enzyme activity.  The IC50 of each compound was 
calculated using Prism
® software (Graph Pad Inc.), and was referred to the potency of standard 
galantamine (IC50 0.6±0.1 μM).  
Cytotoxicity determination was performed according to the sulphorrhodamine B assay protocol 
described in [22].  The paneled cancer cell lines used here include MCF-7 (human breast 
adenocarcinoma), HeLa (human cervical carcinoma), KB (human oral epidermoid carcinoma), and 
HT-29 (colorectal carcinoma).  The potency was referred to camptothecin as a standard reference 
(IC50s 0.6-6 × 10
-6 μM).   Mar. Drugs 2008, 6                                                  
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